Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

France is launching a new study which will enrol 3000 new pre-exposure prophylxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS

Published
6 hours ago
By
Roger Pebody
Dutch study finds out whether gay men prefer daily or on-demand PrEP

In Europe, whether through national programmes or in trials, people are more often than not being given the choice of taking pre-exposure prophylaxis (PrEP) daily or intermittently

Published
9 hours ago
By
Gus Cairns
Philippines trials anti-HIV drug as cases hit record high

The Philippines has kicked off a pilot project offering anti-HIV drugs to gays and transgender women as new infection rates in the country buck global trends and hit a record high.

Published
27 July 2017
From
Thomson Reuters
Dapivirine vaginal ring safe, acceptable for HIV prevention in teens

A monthly vaginal ring containing the antiretroviral dapivirine has demonstrated efficacy in girls younger than 18 years, according to phase 2a study results presented at the IAS Conference on HIV Science.

Published
27 July 2017
From
Healio
Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus

The apparently greater susceptibility of sub-Saharan African women to HIV infection has led researchers to consider the various potential synergies between HIV and other genital infections or conditions of the vaginal microbiome. A recent study brings this wider perspective to bear on mother-to-child transmission, casting some fresh light on the complex interrelation between the ‘vertical’ transmission of HIV and active and Cytomegalovirus (CMV) viruria.

Published
27 July 2017
From
BMJ Group blogs
Rectal products for PrEP: Are they an option?

At the IAS 2017 conference this week, Ian McGowan, MD, PhD, FRCP, from University of Pittsburgh, discussed the need for (and challenges associated with) topical HIV prevention products, and a separate team of researchers presented promising findings from a very early study of a rectal HIV-prevention douche.

Published
27 July 2017
From
BETA blog
Long-acting cabotegravir injection shows promise for HIV prevention

A long-acting injectable formulation of cabotegravir given every 8 weeks produces high enough drug levels in both men and women to offer protection against HIV, according to

Published
27 July 2017
By
Liz Highleyman
Update on PrEP Impact trial in England

In response to stakeholders, Public Health England (PHE) and NHS England have published an update on the PrEP Impact Trial.

Published
26 July 2017
From
Gov.uk
Medical male circumcision for HIV has benefits for women too

South African women whose most recent sexual partner was circumcised are less likely to have HIV, suggesting that the voluntary medical male circumcision programmes have benefits for

Published
26 July 2017
By
Roger Pebody
Demonstration projects explore the feasibility of PrEP for adolescents and young women in South Africa

One of the first studies to explore the acceptability, safety and use of pre-exposure prophylaxis (PrEP) in adolescents in an African context has found that PrEP was

Published
26 July 2017
By
Roger Pebody
← First12345...542Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.